TipRanks
Inhibikase Therapeutics (IKT)
NASDAQ:IKT
US Market
IKT
Inhibikase Therapeutics
RESEARCH TOOLSreports
Want to see IKT full AI Analyst Report?

Inhibikase Therapeutics (IKT) Balance Sheet

380 Followers

Inhibikase Therapeutics Balance Sheet

Inhibikase Therapeutics's total assets for Q2 2026 were $163.59M, a decrease of -5.62% from the previous quarter. IKT total liabilities were $10.26M for the fiscal quarter, a 79.62% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Mar 23Mar 22
Total Assets
$ 181.20M$ 98.60M$ 14.51M$ 24.94M$ 42.47M
Total Liabilities
$ 8.30M$ 3.73M$ 3.53M$ 3.90M$ 4.05M
Total Equity Gross Minority
$ 172.90M$ 94.87M$ 10.98M$ 21.04M$ 38.42M
Other Metrics
Currency in USD

Inhibikase Therapeutics Debt to Assets